Security Snapshot

AdaptHealth Corp. - Common Stock (AHCO) Institutional Ownership

CUSIP: 00653Q102

13F Institutional Holders and Ownership History from Q3 2019 to Q1 2026

Latest Period

Q4 2025

Institutions Reporting

231

Shares (Excl. Options)

139,093,247

Price

$9.96

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Type / Class
Equity / Common Stock
Symbol
AHCO on Nasdaq
Shares outstanding
135,705,353
Price per share
$12.07
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
139,093,247
Total reported value
$1,385,363,243
% of total 13F portfolios
0%
Share change
+2,587,997
Value change
+$27,187,713
Number of holders
231
Price from insider filings
$12.07
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • AHCO - AdaptHealth Corp. - Common Stock is tracked under CUSIP 00653Q102.
  • 231 institutions reported positions in Q4 2025.
  • 7 significant owners is listed from Schedule 13D/13G reporting.

What Changed

  • Holder count moved from 231 to 97 between Q4 2025 and Q1 2026.
  • Reported value moved from $1,385,363,243 to $660,027,369.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 231 institutions filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 00653Q102?
CUSIP 00653Q102 identifies AHCO - AdaptHealth Corp. - Common Stock in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Significant Owners of AdaptHealth Corp. - Common Stock (AHCO) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Flynn James E 8.5% $213,579,981 23,863,685 Deerfield Management Company, L.P. 30 Sep 2025
CASHIN RICHARD M JR 12% $168,960,876 15,864,871 OEP VII GP, L.L.C. 10 Mar 2026
BlackRock, Inc. 11% $138,311,517 14,667,181 BlackRock, Inc. 30 Jun 2025
FMR LLC 5.6% -16% $76,009,093 -$13,428,450 7,631,435 -15% FMR LLC 31 Dec 2025
REINHART PARTNERS, LLC. 5.4% $58,107,184 7,236,262 REINHART PARTNERS, LLC. 31 Mar 2025
DIMENSIONAL FUND ADVISORS LP 5.1% $82,359,579 6,920,973 Dimensional Fund Advisors LP 31 Mar 2026
Jefferies Financial Group Inc. 3.8% $40,943,003 5,098,755 JEFFERIES LLC 31 Dec 2024

As of 31 Dec 2025, 231 institutional investors reported holding 139,093,247 shares of AdaptHealth Corp. - Common Stock (AHCO). This represents 102% of the company’s total 135,705,353 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of AdaptHealth Corp. - Common Stock (AHCO) together control 88% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 12% 15,692,014 +2.9% 0% $156,292,459
OEP CAPITAL ADVISORS, L.P. 10% 13,818,180 0% 100% $137,629,073
VANGUARD GROUP INC 8.7% 11,768,599 +4.4% 0% $117,215,246
DEERFIELD MANAGEMENT COMPANY, L.P. 8.5% 11,477,730 0% 1.5% $114,318,191
SkyKnight Capital, L.P. 6.3% 8,580,443 0% 95% $85,461,212
REINHART PARTNERS, LLC. 6% 8,100,785 +11% 2.4% $80,683,871
FMR LLC 5.6% 7,631,435 -15% 0% $76,009,093
DIMENSIONAL FUND ADVISORS LP 4.7% 6,402,699 +7% 0.01% $63,772,501
STATE STREET CORP 3.2% 4,364,801 +0.1% 0% $43,473,418
SEGALL BRYANT & HAMILL, LLC 2.9% 3,924,519 -8.7% 0.53% $39,088,209
Jefferies Financial Group Inc. 2.8% 3,757,557 -18% 0.31% $37,425,268
GEODE CAPITAL MANAGEMENT, LLC 1.9% 2,627,306 +0.77% 0% $26,172,647
Iron Triangle Partners LP 1.9% 2,609,003 +36% 3% $25,985,670
KENNEDY CAPITAL MANAGEMENT LLC 1.8% 2,408,038 +15% 0.51% $23,984,058
PALISADE CAPITAL MANAGEMENT, LP 1.7% 2,291,847 -12% 0.68% $22,826,796
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1.6% 2,232,787 +17% 0% $22,238,559
PRINCIPAL FINANCIAL GROUP INC 1.6% 2,225,959 +0.15% 0.01% $22,170,553
ROYAL BANK OF CANADA 1.3% 1,719,352 -3.3% 0% $17,125,000
Invesco Ltd. 1.2% 1,677,260 -8% 0% $16,705,509
LAZARD ASSET MANAGEMENT LLC 0.91% 1,236,790 +16% 0.02% $12,318,428
AMERIPRISE FINANCIAL INC 0.91% 1,234,048 -2.6% 0% $12,291,119
NORTHERN TRUST CORP 0.88% 1,200,774 -3.6% 0% $11,959,710
MORGAN STANLEY 0.76% 1,029,324 +27% 0% $10,252,088
BRIDGEWAY CAPITAL MANAGEMENT, LLC 0.74% 997,702 -1.5% 0.21% $9,937,112
NEW YORK STATE COMMON RETIREMENT FUND 0.62% 841,082 +1.4% 0.01% $8,377,177

Institutional Holders of AdaptHealth Corp. - Common Stock (AHCO) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 55,503,547 $660,027,369 +$30,211,167 $11.90 97
2025 Q4 139,093,247 $1,385,363,243 +$27,187,713 $9.96 231
2025 Q3 136,878,737 $1,225,455,664 -$532,641 $8.95 224
2025 Q2 136,902,285 $1,291,003,973 +$41,802,452 $9.43 217
2025 Q1 132,979,873 $1,440,668,696 +$29,808,332 $10.84 227
2024 Q4 131,085,924 $1,247,980,281 +$63,505,202 $9.52 199
2024 Q3 123,603,441 $1,387,937,026 +$60,196,600 $11.23 214
2024 Q2 116,370,859 $1,163,718,130 +$20,268,205 $10.00 206
2024 Q1 113,696,291 $1,308,575,762 +$15,365,696 $11.51 207
2023 Q4 112,806,581 $822,358,955 -$17,053,263 $7.29 191
2023 Q3 113,583,975 $1,033,596,200 +$36,166,490 $9.10 189
2023 Q2 108,310,074 $1,318,125,081 -$41,668,212 $12.17 180
2023 Q1 111,175,611 $1,381,908,955 +$54,942,279 $12.43 165
2022 Q4 106,254,447 $2,043,346,452 +$63,548,944 $19.22 189
2022 Q3 102,994,087 $1,935,791,587 +$183,726,139 $18.78 174
2022 Q2 93,188,698 $1,682,829,245 -$26,346,076 $18.04 143
2022 Q1 94,982,413 $1,523,114,678 +$59,280,029 $16.03 147
2021 Q4 88,175,376 $2,152,259,321 +$198,094,488 $24.46 147
2021 Q3 72,216,867 $1,681,937,067 +$71,699,377 $23.29 139
2021 Q2 68,685,890 $1,882,685,970 +$16,815,759 $27.41 133
2021 Q1 65,167,826 $2,395,786,595 +$789,210,761 $36.76 143
2020 Q4 28,862,834 $1,084,347,205 +$256,339,491 $37.56 131
2020 Q3 25,503,341 $556,879,976 +$332,958,250 $21.81 79
2020 Q2 10,303,667 $165,891,000 -$226,130,665 $16.10 52
2020 Q1 24,351,453 $389,621,000 +$30,369,902 $16.00 34
2019 Q4 22,596,299 $247,953,000 +$235,213,000 $10.98 22
2019 Q3 1,249,993 $12,740,000 +$12,740,000 $10.19 2
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .